Somatostatin messenger RNA-containing neurons in Alzheimer's disease: an in situ hybridization study in hippocampus, parahippocampal cortex and frontal cortex.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Neuroscience

• Publication date

  1994-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0306-4522(94)90399-9PMID 7838375
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuropathological stageing of Alzheimer-related changes

  2004cited by this paper
• Hippocampal and Parahippocampal Somatostatin 28 and Neuropeptide Y Containing Neurons in Alzheimer's Disease (Part 1 of 2)

  1992cited by this paper
• On the Stability of Messenger RNA and Ribosomal RNA in the Brains of Control Human Subjects and Patients with Alzheimer's Disease

  1992cited by this paper
• Somatostatin in Alzheimer's disease and depression.

  1992cited by this paper
• Regional distribution of neuropeptide somatostatin gene expression in the human brain

  1992cited by this paper
• Somatostatin-gene expression in the postmortem adult and fetal human brain.

  1992cited by this paper
• Relative sparing of nitric oxide synthase–containing neurons in the hippocampal formation in Alzheimer's disease

  1992cited by this paper
• A selective loss of somatostatin in the hippocampus of patients with temporal lobe epilepsy

  1991cited by this paper
• Entorhinal cortex pathology in Alzheimer's disease

  1991cited by this paper
• Somatostatin Depletion by Cysteamine Increases Somatostatin Binding and Growth Hormone‐Releasing Factor Messenger Ribonucleic Acid in the Arcuate Nucleus

  1991cited by this paper
• The use ofin situ hybridization histochemistry for the study of neuropeptide gene expression in the human brain

  1990cited by this paper
• A quantitative assessment of somatostatin-like and neuropeptide Y-like immunostained cells in the frontal and temporal cortex of patients with Alzheimer's disease.

  1990cited by this paper
• The role of mRNA and protein stability in gene expression

  1989cited by this paper
• Subpopulations of somatostatin 28-immunoreactive neurons display different vulnerability in senile dementia of the Alzheimer type.

  1989cited by this paper
• Cortical somatostatin, neuropeptide Y, and NADPH diaphorase neurons: Normal anatomy and alterations in alzheimer's disease

  1988cited by this paper
• Somatostatin immunoreactive neurons in the human hippocampus and cortex shown by immunogold/silver intensification on vibratome sections: Coexistence with neuropeptide Y neurons, and effects alzheimer‐type dementia

  1987cited by this paper
• Somatostatin- and neuropeptide Y-immunoreactive neurons in the neocortex in senile dementia of Alzheimer's type.

  1986cited by this paper
• Somatostatin: alterations in the central nervous system in neurological diseases.

  1986cited by this paper
• Location of neuronal tangles in somatostatin neurones in Alzheimer's disease

  1985cited by this paper
• Somatostatin-like immunoreactivity within neuritic plaques.

  1985cited by this paper
• Role of the senile plaque in neuropeptide deficits of Alzheimer's disease.

  1985cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper
• Neuropeptides in aging and dementia.

  1984cited by this paper
• Cloning and characterization of a mRNA-encoding rat preprosomatostatin.

  1983cited by this paper
• Neuropeptide coexistence in human cortical neurones

  1982cited by this paper

• Genetic ablation of dentate hilar somatostatin-positive GABAergic interneurons is sufficient to induce cognitive impairment

  2023cites this paper
• Royal jelly coordinately enhances hippocampal neuronal expression of somatostatin and neprilysin genes conferring neuronal protection against toxic soluble amyloid-β oligomers implicated in Alzheimer’s disease pathogenesis

  2018cites this paper
• Cortical cells reveal APP as a new player in the regulation of GABAergic neurotransmission

  2017cites this paper
• The Nonhuman Primate Hippocampus: Neuroanatomy and Patterns of Cortical Connectivity

  2017cites this paper
• Anti‐diabetic and neuroprotective effects of pancreatic islet transplantation into the central nervous system

  2016cites this paper
• α-Melanocyte Stimulating Hormone as a Potential Therapy for Alzheimer`s Disease.

  2016cites this paper
• Age‐associated changes in hippocampal‐dependent cognition in Diversity Outbred mice

  2014cites this paper
• Neurochemical phenotype of cytoglobin-expressing neurons in the rat hippocampus.

  2014cites this paper
• α-Melanocyte Stimulating Hormone Prevents GABAergic Neuronal Loss and Improves Cognitive Function in Alzheimer's Disease

  2014cites this paper
• Methylation analysis of SST and SSTR4 promoters in the neocortex of Alzheimer's disease patients.

  2014cites this paper
• Reduced brain somatostatin in mood disorders: a common pathophysiological substrate and drug target?

  2013cites this paper
• Role of the 39-kDa receptor-associated protein (RAP) in Alzheimer's disease

  2012cites this paper
• Implications of age and diet on canine cerebral cortex transcription.

  2009cites this paper
• Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia

  2008cites this paper
• New insights into brain BDNF function in normal aging and Alzheimer disease.

  2008cites this paper
• Protective effect of BDNF against beta-amyloid induced neurotoxicity in vitro and in vivo in rats.

  2008cites this paper
• 17Beta-estradiol protects depletion of rat temporal cortex somatostatinergic system by beta-amyloid.

  2007cites this paper
• Twenty-first century brain banking. Processing brains for research: the Columbia University methods

  2007cites this paper
• INVOLVEMENT OF SOMATOSTATIN RECEPTOR SUBTYPES IN MEMBRANE ION CHANNEL MODIFICATION BY SOMATOSTATIN IN PITUITARY SOMATOTROPES

  2007cites this paper
• β‐Amyloid increases somatostatin expression in cultured cortical neurons

  2007cites this paper
• 17β-Estradiol protects depletion of rat temporal cortex somatostatinergic system by β-amyloid

  2007cites this paper
• Beta-amyloid increases somatostatin expression in cultured cortical neurons.

  2007cites this paper
• Somatostatin in the dentate gyrus.

  2007cites this paper
• Effects of single and continuous administration of amyloid beta-peptide (25-35) on adenylyl cyclase activity and the somatostatinergic system in the rat frontal and parietal cortex.

  2005cites this paper
• Somatostatin-like immunoreactivity, its molecular forms and monoaminergic metabolites in aged and demented patients with Parkinson's disease — effect of L-Dopa

  2005cites this paper
• Neurochemical parameters in senile dementia of the Alzheimer type

  2005cites this paper
• Protective effects of insulin‐like growth factor‐I on the somatostatinergic system in the temporal cortex of β‐amyloid‐treated rats

  2005cites this paper
• Changes in the levels of neuropeptides and their metabolizing enzymes in the brain regions of nucleus basalis magnocellularis-lesioned rats.

  2003cites this paper
• Cellular biology of somatostatin receptors.

  2001cites this paper
• Immunohistochemical estimation of rat brain somatostatin on avoidance learning impairment induced by thiamine deficiency.

  2000cites this paper
• Alterations in bcl-2 and caspase gene family protein expression in human temporal lobe epilepsy

  2000cites this paper
• Early Histological Maturation in the Hippocampus of the Guinea Pig

  2000cites this paper
• Chapter IV Chemical neuroanatomy of the hippocampal formation and the perirhinal and parahippocampal cortices

  1999cites this paper
• Aberrant presenilin-1 expression downregulates LDL receptor-related protein (LRP): is LRP central to Alzheimer's disease pathogenesis?

  1999cites this paper
• A novel role for receptor-associated protein in somatostatin modulation: implications for Alzheimer's disease.

  1999cites this paper
• Altered hippocampal kainate-receptor mRNA levels in temporal lobe epilepsy patients.

  1998cites this paper
• Loss of somatostatin-like immunoreactivity in the frontal cortex of Alzheimer patients carrying the apolipoprotein epsilon 4 allele.

  1998cites this paper
• Selective increase in somatostatin mRNA expression in human basal ganglia in Parkinson's disease.

  1997cites this paper
• Neuropeptides and Alzheimer's Disease Pathology

  1997cites this paper
• Neurochemical differences in the CSF between Binswanger's and Alzheimer's disease.

  1997cites this paper
• Granule cell mRNA levels for BDNF, NGF, and NT-3 correlate with neuron losses or supragranular mossy fiber sprouting in the chronically damaged and epileptic human hippocampus.

  1997cites this paper
• Somatostatin and brain-derived neurotrophic factor mRNA expression in the primate brain: decreased levels of mRNAs during aging.

  1997cites this paper
• Human hippocampal AMPA and NMDA mRNA levels in temporal lobe epilepsy patients.

  1997cites this paper
• Molecular forms of somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with senile dementia of the Alzheimer type.

  1997cites this paper
• Naturally occurring somatostatin and vasoactive intestinal peptide inhibitors. Isolation of alkaloids from two marine sponges.

  1996cites this paper
• Neuronal nitric oxide synthase (nNOS) mRNA expression and NADPH-diaphorase staining in the frontal cortex, visual cortex and hippocampus of control and Alzheimer's disease brains.

  1996cites this paper
• Immunohistochemical localization of the somatostatin SST2(A) receptor in the rat brain and spinal cord.

  1996cites this paper
• Distribution of substance P-immunoreactive neurons and fibers in the monkey hippocampal formation.

  1996cites this paper
• Entorhinal cortex modules of the human brain

  1996cites this paper
• Somatostatin, its molecular forms and monoaminergic transmitter metabolites in Binswanger's disease. Neurochemical-neuropathological considerations.

  1996cites this paper
• Somatostatin-positive neurons in the different parts of the brain in normal aging and Alzheimer's disease.

  1996cites this paper
• Correlations between Water Maze Performance and Cortical Somatostatin mRNA and High‐affinity Binding Sites During Ageing in Rats

  1996cites this paper
• Cellular localisation and co-expression of somatostatin receptor messenger RNAs in the human brain.

  1995cites this paper
• Anatomical localization and regulation of somatostatin gene expression in the basal ganglia and its clinical implications.

  1995cites this paper